NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port efficacy with microchip and sensor technology, NGP measures, monitors and reports physiological body functions in vivo over the course of disease and treatment.
In this episode, Founder and CEO Kathy Skinner shares the details of how this port advances care for a very important patient population and how its quickly gaining momentum.
Ai Medica makes it easy to create clinical and economic value from EHR data using evidence based medicine. They have built a platform on...
PathKeeper is an innovative robotic company founded in Israel.The company's disruptive, proprietary technology provides laser-like accuracy for spinal procedures. The unique technology tracks the...
Dr. Kay is a Foot & Ankle surgeon based in Ohio. Like many physicians, he and his colleagues saw better ways to treat patients...
